SARM1 Therapy(Lmito Therapeutics)

N/A

Report date: 2024/11/21 17:06:04
NME

Base Information

Drug NameSARM1 Therapy(Lmito Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD(+) hydrolase SARM1 modulators
TargetsNAD(+) hydrolase SARM1
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLmito Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLmito Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A